Ashton L - Search Results

1

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks.

Babiker A, Darbyshire J, Pezzotti P, Porter K, Rezza G, Walker SA, Beral V, Coutinho R, Del Amo J, Gill N, Lee C, Meyer L, Tyrer F, Dabis F, Thiebaut R, Lawson-Aye S, Boufassa F, Hamouda O, Fischer K, Pezzotti P, Rezza G, Touloumi G, Hatzakis A, Karafoulidou A, Katsarou O, Brettle R, del Romero J, Prins M, van Benthem B, Kirk O, Pederson C, Hernández Aguado I, Pérez-Hoyos S, Eskild A, Bruun JN, Sannes M, Sabin C, Lee C, Johnson AM, Phillips AN, Francioli P, Vanhems P, Egger M, Rickenbach M, Cooper D, Kaldor J, Ashton L, Vizzard J, Muga R, Day NE, De Angelis D; CASCADE Collaboration. Babiker A, et al. Among authors: ashton l. Int J Epidemiol. 2002 Oct;31(5):951-8. doi: 10.1093/ije/31.5.951. Int J Epidemiol. 2002. PMID: 12435766 Free PMC article.

2

The historical development of epidemiological methods for studying HIV-1 disease progression.

Ashton LJ, Kaldor JM. Ashton LJ, et al. J Epidemiol Biostat. 2000;5(1):67-78. J Epidemiol Biostat. 2000. PMID: 10885873 No abstract available.

3

Heterozygosity for CCR5-Delta32 but not CCR2b-64I protects against certain intracellular pathogens.

Ashton LJ, Stewart GJ, Biti R, Law M, Cooper DA, Kaldor JM. Ashton LJ, et al. HIV Med. 2002 Apr;3(2):91-6. doi: 10.1046/j.1468-1293.2002.00106.x. HIV Med. 2002. PMID: 12010355 Free article.

4

Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.

Keoshkerian E, Ashton LJ, Smith DG, Ziegler JB, Kaldor JM, Cooper DA, Stewart GJ, Ffrench RA. Keoshkerian E, et al. J Med Virol. 2003 Dec;71(4):483-91. doi: 10.1002/jmv.10525. J Med Virol. 2003. PMID: 14556259

5

HIV infection in recipients of blood products from donors with known duration of infection.

Ashton LJ, Learmont J, Luo K, Wylie B, Stewart G, Kaldor JM. Ashton LJ, et al. Lancet. 1994 Sep 10;344(8924):718-20. doi: 10.1016/s0140-6736(94)92210-1. Lancet. 1994. PMID: 7915778

6

Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group.

Ashton LJ, Carr A, Cunningham PH, Roggensack M, McLean K, Law M, Robertson M, Cooper DA, Kaldor JM. Ashton LJ, et al. AIDS Res Hum Retroviruses. 1998 Jan 20;14(2):117-21. doi: 10.1089/aid.1998.14.117. AIDS Res Hum Retroviruses. 1998. PMID: 9462921

7

Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group.

Rhodes DI, Ashton L, Solomon A, Carr A, Cooper D, Kaldor J, Deacon N. Rhodes DI, et al. Among authors: ashton l. J Virol. 2000 Nov;74(22):10581-8. doi: 10.1128/jvi.74.22.10581-10588.2000. J Virol. 2000. PMID: 11044102 Free PMC article.

8

Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group.

Stewart GJ, Ashton LJ, Biti RA, Ffrench RA, Bennetts BH, Newcombe NR, Benson EM, Carr A, Cooper DA, Kaldor JM. Stewart GJ, et al. Among authors: ashton lj. AIDS. 1997 Dec;11(15):1833-8. doi: 10.1097/00002030-199715000-00007. AIDS. 1997. PMID: 9412701

9

Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.

Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, Martinez OP, Meyer L, Michael NL, Operskalski E, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Stewart GJ, Theodorou ID, Ullum H, Vicenzi E, Vlahov D, Wilkinson D, Workman C, Zagury JF, O'Brien TR; International Meta-Analysis of HIV Host Genetics. Ioannidis JP, et al. Among authors: ashton lj. Ann Intern Med. 2001 Nov 6;135(9):782-95. doi: 10.7326/0003-4819-135-9-200111060-00008. Ann Intern Med. 2001. PMID: 11694103

10

CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group.

Clegg AO, Ashton LJ, Biti RA, Badhwar P, Williamson P, Kaldor JM, Stewart GJ. Clegg AO, et al. Among authors: ashton lj. AIDS. 2000 Jan 28;14(2):103-8. doi: 10.1097/00002030-200001280-00004. AIDS. 2000. PMID: 10708279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters